Skip to content
GLP-1 Scorecard
Menu
Site position #208

Nurx

Published by GLP-1 ScorecardUpdated

Established women's telehealth brand offering tiered GLP-1 weight loss programs.

Visit NurxWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$179/mo (starting dose, compounded)
Tirzepatide
$179/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Nurx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value61/100
Dose & formulation77/100
Clinical oversight79/100
Labs & monitoring52/100
Fulfillment65/100
Contract terms55/100

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

What to consider

  • Limited public information on program details

Bottom line — Grade C

Best for: Shoppers who want mainstream telehealth GLP-1 access.

Site position #208 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Nurx — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Nurx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Nurx's site. Not medical advice; see our disclosure.

← Back to the scorecard